Representative Literature References

Click a row to open its literature reference.

Product

Separation Mode

Broad Sample Type

Specific Sample

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next View All

Year

Product

Sep. Mode

Broad Sample Category

Specific Sample

Title

2018	Zenix SEC-300, 3um, 300 A 7.8 x 300 mm	213300-7830	SEC	BsMAb	Cetuximab	EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies https://doi.org/10.1080/19420862.2018.1519631
2018	GP-C18	101185-4615	RP	Small Molecule	Sildenafil and Carbamazepine	Influence of Energy Drinks on Pharmacokinetic Parameters of Sildenafil in Rats Biomedical & Pharmacology Journal 11.3 (2018): 1317.
2018	Proteomix SAX-NP5	403NP5-4625	IEX	BsMAb	native IgG1 and pI engineered	A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats Methods 154 (2019): 38-50.
2018	Zenix SEC 300	213300-7830	SEC	PEG/PEGylated Protein	rFVIII	A comparative analysis of heterogeneity in commercially available recombinant factor VIII products Haemophilia. 2018; 24: 880– 887.
2018	SRT SEC-500	215500-4630	SEC	Antibody	α4β2–Fab complexes	Structural principles of distinct assemblies of the human α4β2 nicotinic receptor Nature volume 557, pages261–265 (2018)
2018	SRT-C SEC-300	235300-4630	SEC	Antibody	Antibody	Mobile Affinity Sorbent Chromatography Anal. Chem. 2018, 90, 3, 1668–1676
2018	Zenix SEC-300	213300LS-7830	SEC	Fusion Protein	IP268 and Dulaglutide (IP118)	Mass spectrometry-based methods to explore higher-order protein structure: generating a fingerprint for biologics Diss. University of Antwerp, 2018.
2018	SRT-150	215150	SEC	Membrane Protein	FcγR	Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands Biotechnology and bioengineering 115.5 (2018): 1265-1278.
2018	SRT-2000	215980P-4630	SEC	DNA/RNA/OLIGO	circRNA	Engineering circular RNA for potent and stable translation in eukaryotic cells Nat Commun 9, 2629 (2018).
2018	Zenix SEC-300	213300-7830	SEC	BsMAb	Cetuximab	EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies MAbs. Vol. 10. No. 8. Taylor & Francis, 2018.

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next View All

Products | Privacy Policy | Career | Contact Us

By Separation Mode	By Brand	By Sample Based Application
Size Exclusion Ion Exchange Hydrophobic Interaction Ion Exclusion Sub-2 UHPLC Purification Reversed Phase Mixed-mode Phase HILIC View All	SEC-MALS Unix / Unix-C Zenix / Zenix-C SRT / SRT-C SRT-10 / SRT-10C Proteomix HIC / IEX Antibodix Carbomix Proteomix RP View All	ADC Antibody Biosimilar Carbohydrate Cell Lysate DNA/RNA Fusion Protein Glycan Glycoprotein Heparin	Insulin Membrane Protein Organic Acid PEG/PEGylated Protein Peptide Polymer Protein Vaccine/VLP Others